---
schema_version: "secwatch.filing_event.v1"
accession: "0001847903-23-000107"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:16:48.295177+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Centessa posts updated corporate presentation; no material new facts disclosed in filing

## Summary
- Updated corporate slide deck posted to Centessa website on June 9, 2023.
- Exhibit 99.1 contains only boilerplate disclaimers and a title slide; substantive content not available.
- No financial results, pipeline updates, or guidance changes included in the filing body.

## SEC filing metadata
- accession: 0001847903-23-000107
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000184790323000107/0001847903-23-000107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000184790323000107/cnta-20230609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001847903-23-000107
- JSON: https://secwatch.observer/filing/0001847903-23-000107.json
- Plain text: https://secwatch.observer/filing/0001847903-23-000107.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.